Jarisch R, Hemmer W
FAZ-Floridsdorfer Allergiezentrum, Wien.
Wien Med Wochenschr. 1996;146(15):422-5.
Specific immunotherapy is the treatment of choice in the therapy of inhalant allergies. Application route and dose regimen, selection and quality of allergens, as well as the individual patient represent different variables of immunotherapy to be considered. Premedication by oral antihistamines is mandatory for the reduction of side effects. Histamine-intolerance represents a contraindication for immunotherapy. Specific immunotherapy is highly efficacious leading to a 50-100% reduction of symptoms in nearly 90% of patients.
特异性免疫疗法是吸入性过敏治疗的首选方法。免疫疗法的应用途径和剂量方案、变应原的选择和质量以及个体患者都是需要考虑的不同变量。口服抗组胺药进行预处理对于减少副作用是必需的。组胺不耐受是免疫疗法的禁忌证。特异性免疫疗法非常有效,近90%的患者症状可减轻50%至100%。